PCE is proud to announce its membership in the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA), a pioneering initiative that, for the first time, brings together leading Pancreatic Ductal Adenocarcinoma (PDAC) investigators from across the Western and Eastern Hemispheres.
TAPCA represents the largest collaborative network of translational research and surgery experts exclusively dedicated to pancreatic cancer. By joining this alliance, PCE strengthens its commitment to fostering international collaboration and advancing research efforts to improve outcomes for people affected by pancreatic cancer.